English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51209092    線上人數 :  605
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"su y c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 141-150 / 436 (共44頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-12-30T02:44:13Z Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study Tsai M.-S.;Chang S.-Y.;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Shan-Chwen Chang; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; SHAN-CHWEN CHANG
臺大學術典藏 2020-12-30T02:44:11Z Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study Su Y.-C.; Liu W.-C.; Lin Y.-T.; Sun H.-Y.; Chang S.-Y.; Lin S.-W.; Huang S.-H.; Hung C.-C.; SHAN-CHWEN CHANG
臺大學術典藏 2020-12-30T02:43:48Z Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan Lai C.-C.; Hung C.-C.; Chen M.-Y.; Sun H.-Y.; Lu C.-L.; Tseng Y.-T.; Chang S.-F.; Su Y.-C.; Liu W.-C.; Hsieh C.-Y.; Wu P.-Y.; Chang S.-Y.; SHAN-CHWEN CHANG; Lai C.-C.;Hung C.-C.;Chen M.-Y.;Sun H.-Y.;Lu C.-L.;Tseng Y.-T.;Chang S.-F.;Su Y.-C.;Liu W.-C.;Hsieh C.-Y.;Wu P.-Y.;Chang S.-Y.;Shan-Chwen Chang
臺大學術典藏 2020-12-30T02:43:39Z Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan Liu W.-C.; Lin S.-W.; Tsai M.-S.; Chang S.-Y.; Yang C.-J.; Tseng Y.-T.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; Hung C.-C.; SHAN-CHWEN CHANG
臺大學術典藏 2020-12-30T02:43:34Z Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy SHAN-CHWEN CHANG; Chang S.-F.; Chang S.-Y.; Su Y.-C.; Su C.-T.; Liu W.-C.; Chuang Y.-C.; Hung C.-C.; Lu C.-L.
臺大學術典藏 2020-12-30T02:43:02Z Increasing incidence of recent hepatitis C virus infection among persons seeking voluntary counselling and testing for HIV and sexually transmitted infections in Taiwan Sun H.-Y.; SHAN-CHWEN CHANG; Chang L.-H.; Wu C.-H.; Su Y.-C.; Wu P.-Y.; Luo Y.-Z.; Liu W.-C.; Chang S.-Y.; Hung C.-C.; Tsai J.-C.; Tsai J.-C.;Hung C.-C.;Chang S.-Y.;Liu W.-C.;Wu C.-H.;Su Y.-C.;Wu P.-Y.;Luo Y.-Z.;Chang L.-H.;Sun H.-Y.;Shan-Chwen Chang
臺大學術典藏 2020-12-29T05:33:52Z Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan Cheng C.-L.; Chang S.-Y.; Lin P.-H.; Chen M.-Y.; HSIN-YUN SUN; Hsieh S.-M.; Sheng W.-H.; Su Y.-C.; Su L.-H.; Chang S.-F.; Liu W.-C.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2020-12-29T05:33:52Z Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy Huang S.-H.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Chiang C.;Hsiao C.-F.;Hsin-Yun Sun;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Chiang C.; Hsiao C.-F.; HSIN-YUN SUN; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2020-12-29T05:33:50Z Risk of active tuberculosis in HIV-infected patients in Taiwan with free access to HIV care and a positive T-Spot.TB test Liu W.-C.; Hsueh P.-R.; HSIN-YUN SUN; Su Y.-C.; Chang S.-Y.; Hung C.-C.; Chang S.-C.
臺大學術典藏 2020-12-29T05:33:43Z HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan Chang S.-C.; Hung C.-C.; Su Y.-C.; HSIN-YUN SUN; Liu W.-C.; Su L.-H.; Cheng A.; Liu C.-H.; Chang S.-Y.; Huang M.-H.

顯示項目 141-150 / 436 (共44頁)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
每頁顯示[10|25|50]項目